JP2003512441A5 - - Google Patents

Download PDF

Info

Publication number
JP2003512441A5
JP2003512441A5 JP2001532809A JP2001532809A JP2003512441A5 JP 2003512441 A5 JP2003512441 A5 JP 2003512441A5 JP 2001532809 A JP2001532809 A JP 2001532809A JP 2001532809 A JP2001532809 A JP 2001532809A JP 2003512441 A5 JP2003512441 A5 JP 2003512441A5
Authority
JP
Japan
Prior art keywords
protein drug
mucosa
activity
domain
pseudomonas exotoxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001532809A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003512441A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/029080 external-priority patent/WO2001030392A2/en
Publication of JP2003512441A publication Critical patent/JP2003512441A/ja
Publication of JP2003512441A5 publication Critical patent/JP2003512441A5/ja
Withdrawn legal-status Critical Current

Links

JP2001532809A 1999-10-22 2000-10-18 極性上皮細胞層を横断するタンパク質の送達 Withdrawn JP2003512441A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16092399P 1999-10-22 1999-10-22
US60/160,923 1999-10-22
PCT/US2000/029080 WO2001030392A2 (en) 1999-10-22 2000-10-18 Delivery of proteins across polar epithelial cell layers

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011254351A Division JP2012051939A (ja) 1999-10-22 2011-11-21 極性上皮細胞層を横断するタンパク質の送達

Publications (2)

Publication Number Publication Date
JP2003512441A JP2003512441A (ja) 2003-04-02
JP2003512441A5 true JP2003512441A5 (cg-RX-API-DMAC7.html) 2005-06-30

Family

ID=22579051

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001532809A Withdrawn JP2003512441A (ja) 1999-10-22 2000-10-18 極性上皮細胞層を横断するタンパク質の送達
JP2011254351A Pending JP2012051939A (ja) 1999-10-22 2011-11-21 極性上皮細胞層を横断するタンパク質の送達

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011254351A Pending JP2012051939A (ja) 1999-10-22 2011-11-21 極性上皮細胞層を横断するタンパク質の送達

Country Status (8)

Country Link
US (1) US7824695B1 (cg-RX-API-DMAC7.html)
EP (1) EP1242122B1 (cg-RX-API-DMAC7.html)
JP (2) JP2003512441A (cg-RX-API-DMAC7.html)
AT (1) ATE444081T1 (cg-RX-API-DMAC7.html)
AU (1) AU784657B2 (cg-RX-API-DMAC7.html)
CA (1) CA2389302C (cg-RX-API-DMAC7.html)
DE (1) DE60043070D1 (cg-RX-API-DMAC7.html)
WO (1) WO2001030392A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE307208T1 (de) * 1997-07-11 2005-11-15 Us Gov Health & Human Serv Pseudomonas exotoxin-a-ähnliche chimerische immunogene
EP1242122B1 (en) 1999-10-22 2009-09-30 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Delivery of proteins across polar epithelial cell layers
US7713737B2 (en) 2004-10-04 2010-05-11 Trinity Biosystems, Inc. Methods and compositions for needleless delivery of macromolecules
US7666991B2 (en) 2005-12-05 2010-02-23 Trinity Biosystems, Inc. Compositions for needleless delivery of antibodies
US20090148401A1 (en) * 2005-12-05 2009-06-11 Trinity Biosystems, Inc. Methods and compositions for needleless delivery of binding partners
EP2010205A2 (en) * 2006-03-16 2009-01-07 Trinity Biosystems, Inc. Methods for increasing the size of animals using needleless delivery constructs
US11246915B2 (en) 2010-09-15 2022-02-15 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
PL3762009T3 (pl) 2018-03-08 2022-09-12 Applied Molecular Transport Inc. Pochodzące z toksyny konstrukty dostarczające do dostarczania doustnego
SG11202104734YA (en) 2018-11-07 2021-06-29 Applied Molecular Transport Inc Cholix-derived carriers for oral delivery of heterologous payload
MX2022001975A (es) 2019-08-16 2022-03-11 Applied Molecular Transport Inc Composiciones, formulaciones y produccion y purificacion de interleucinas.

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
EP0654040A1 (en) * 1992-06-23 1995-05-24 Interactive Biologics Associates Pharmaceutical composition containing botulinum b complex
AU7694594A (en) * 1993-09-06 1995-03-27 Menarini Ricerche Sud S.P.A. Ribosome inactivating proteins extracted from seeds of saponaria ocymoides and vaccaria pyramidata, their preparation and immunotoxins containing them
DK0759944T3 (da) 1994-05-13 2001-11-26 Biovation Ltd Forbedringer af og relateret til peptidfremføring
US6426075B1 (en) * 1996-11-06 2002-07-30 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protease-activatable pseudomonas exotoxin A-like proproteins
US6086900A (en) * 1997-03-26 2000-07-11 Board Of Regents, The University Of Texas Systems Methods and compositions for using membrane-penetrating proteins to carry materials across cell membranes
US20030054012A1 (en) 2000-05-12 2003-03-20 Fitzgerald David J. Pseudomonas exotoxin a-like chimeric immunogens for eliciting a secretory iga-mediated immune response
ATE307208T1 (de) * 1997-07-11 2005-11-15 Us Gov Health & Human Serv Pseudomonas exotoxin-a-ähnliche chimerische immunogene
US6472140B1 (en) * 1997-09-05 2002-10-29 The General Hospital Corporation α-2- macroglobulin therapies and drug screening methods for Alzheimer's disease.
EP1224290B1 (en) 1999-10-22 2006-06-28 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Disulfide conjugated cell toxins and methods of making and using them
EP1242122B1 (en) 1999-10-22 2009-09-30 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Delivery of proteins across polar epithelial cell layers
DK1379550T3 (da) 2000-12-21 2009-07-06 Us Gov Health & Human Serv Et kimært protein omfattende non-toxisk pseudomonas exotoxin A og en type IV pilin sekvenser

Similar Documents

Publication Publication Date Title
JP2025041812A5 (cg-RX-API-DMAC7.html)
Sato et al. Further studies on the site-specific protein modification by microbial transglutaminase
JP2001523465A5 (cg-RX-API-DMAC7.html)
KR100484084B1 (ko) 키메라성 폴리펩타이드, 이의 제조 방법 및 용도
JP3872105B2 (ja) インスリン誘導体
CN1195551C (zh) 控制细胞活性的新试剂
EP1472351B1 (en) Amino acid sequences capable of facilitating penetration across a biological barrier
Mita et al. Receptors for T cell-replacing factor/interleukin 5. Specificity, quantitation, and its implication.
JP2010507391A (ja) 組織傷害の修復におけるストロマ細胞由来因子1のプロテアーゼ耐性変異体
ATE169959T1 (de) Anthrax-toxin-fusionsproteine und deren verwendungen
JP2020508691A5 (cg-RX-API-DMAC7.html)
JPH0755151B2 (ja) 選定蛋白質およびそれをコードする組替えdna分子
JP2002513556A5 (cg-RX-API-DMAC7.html)
KR20070073863A (ko) 거대분자의 무침 전달을 위한 방법 및 조성물
JP2006149406A5 (cg-RX-API-DMAC7.html)
JP2005537032A5 (cg-RX-API-DMAC7.html)
JP2003507012A5 (cg-RX-API-DMAC7.html)
JP2006187292A5 (cg-RX-API-DMAC7.html)
JP2009536170A (ja) 治療用の抗体標的指向サイトカイン
CN117298254A (zh) 用于口服递送生物活性货物的cholix毒素衍生的融合分子
ES2241040T3 (es) Proteinas hibridas que forman heterodimeros.
CA2389302A1 (en) Delivery of proteins across polar epithelial cell layers
JP2006515744A5 (cg-RX-API-DMAC7.html)
BR9713847A (pt) Polipeptìdeo isolado codificado por um gene semelhante a lipase, composição, composição farmacêutica, fragmento antigênico, ácido nucleico isolado, vetor, célula recombinante, anticorpo, célula de hibridoma, processos para preparar um polipeptìdeo, para triar agonistas ou antagonistas de atividade llg, para a hidrólise enzimática de um éster de fosfatidilcolina, e para melhorar o perfil de lipìdeo no soro de um humano ou outro animal tendo um perfil de lipìdeo indesejável, e, camundongo transgênico.
KR20250140108A (ko) 호흡기 세포융합 바이러스 mRNA 백신